Yao Shihua, Zhao Tiejun, Jin Hai
Department of Thoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
Department of Thoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
Biomed Pharmacother. 2015 Mar;70:72-9. doi: 10.1016/j.biopha.2015.01.013. Epub 2015 Jan 12.
MicroRNAs (miRNAs) can function as tumor suppressors and might provide an efficient strategy for annihilating cancer. Nevertheless, the potential role of miR-325-3p in NSCLC is still unknown. Here, we showed that miR-325-3p was decreased and HMGB1 was increased in 107 NSCLC patients. MiR-325-3p inhibition promoted cell invasion and proliferation, while miR-325-3p upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. Using a bioinformatics method, we further showed that HMGB1 might be a direct target of miR-325-3p and is negatively regulated by miR-325-3p. Down-regulation of miR-325-3p predicts poor prognosis for NSCLC patients. These findings implied that miR-325-3p regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for NSCLC.
微小RNA(miRNA)可作为肿瘤抑制因子,可能为消灭癌症提供一种有效的策略。然而,miR-325-3p在非小细胞肺癌(NSCLC)中的潜在作用仍不清楚。在此,我们发现107例NSCLC患者中miR-325-3p表达降低而高迁移率族蛋白B1(HMGB1)表达升高。通过Transwell和CCK8实验,抑制miR-325-3p可促进细胞侵袭和增殖,而上调miR-325-3p则抑制细胞侵袭和增殖。利用生物信息学方法,我们进一步发现HMGB1可能是miR-325-3p的直接靶点,且受miR-325-3p负调控。miR-325-3p表达下调预示NSCLC患者预后不良。这些发现表明,miR-325-3p通过靶向HMGB1调节细胞侵袭和增殖,可能是NSCLC的一个潜在预后标志物。